Is NTLA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NTLA. It does not provide personalized investment advice.

NTLA (Intellia) Stock Analysis - Financials

Intellia (NTLA) is a publicly traded Healthcare sector company. As of August 19, 2026, NTLA trades at $11.59 with a market cap of $1.69B and a P/E ratio of -3.02. NTLA moved -3.97% today. Year to date, NTLA is +29.03%; over the trailing twelve months it is +8.11%. Its 52-week range spans $5.90 to $28.25. Analyst consensus is buy with an average price target of $20.90. Rallies surfaces NTLA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are NTLA's key financials?

NTLA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NTLA recently traded at $11.59. Market cap is $1.69B. P/E ratio is -3.02. Revenue is $67.67M.

NTLA Key Metrics

Key financial metrics for NTLA
Metric	Value
Price	$11.59
Market Cap	$1.69B
P/E Ratio	-3.02
EPS	$-3.81
Dividend Yield	0.00%
52-Week High	$28.25
52-Week Low	$5.90
Volume	2.86M
Avg Volume	0
Revenue (TTM)	$67.67M
Net Income	$-412.69M
Gross Margin	0.00%

NTLA Analyst Consensus

12 analysts cover NTLA: 0 strong buy, 6 buy, 4 hold, 2 sell, 0 strong sell. Consensus rating is buy. Average price target: $20.90.

Common questions about NTLA

What are NTLA's key financials?: NTLA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NTLA recently traded at $11.59. Market cap is $1.69B. P/E ratio is -3.02. Revenue is $67.67M.
Is NTLA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NTLA. It does not provide personalized investment advice.